Intravenous ascorbic acid: protocol for its application and use.
High dose intravenous(i.v.) ascorbic acid (AA) has been used as therapy for infectious disease from bacterial and viral origin and adjuvant therapy for cancer. In this publication we describe a clinical protocol that has been developed over the past twenty years utilizing high dose i.v. AA as therapy for cancer. This includes principles of treatment, rationale, baseline workup, infusion protocol, precautions and side effects.
Riordan
Hugh D
HD
Center for the Improvement of Human Functioning, Biocommunications Research Institute, Wichita, KS, USA.
Hunninghake
Ronald B
RB
Riordan
Neil H
NH
Jackson
James J
JJ
Meng
Xiaolong
X
Taylor
Paul
P
Casciari
Joseph J
JJ
González
Michael J
MJ
Miranda-Massari
Jorge R
JR
Mora
Edna M
EM
Rosario
Norberto
N
Rivera
Alfredo
A
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D002985:Clinical Protocols; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007262:Infusions, Intravenous; D009369:Neoplasms / Q000188:drug therapy; D014411:Neoplastic Stem Cells / Q000187:drug effects; D014777:Virus Diseases / Q000188:drug therapy
D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D001205:Ascorbic Acid